← Back to Patent Explorer
US4846786A Expired / Lapsed US ⏱️ 0.0 years remaining

Bioreactor containing suspended, immobilized species

Assignee: Massachusetts Institute of Technology
•
Filing: 1987-04-30
•
Granted: 1989-07-11
•
Expires: 2007-04-30
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A reactor system especially suited for removal of chemical species from the bloodstream or other biological solutions containing suspended material. The reactor contains species such as enzymes, antibodies, receptors, anti-toxins, and a variety of drugs or inorganic compounds immobilized on particulate supports and/or solid phase adsorbents which react with specific materials under the appropriate conditions. The reactor chamber is cylindrical and may optionally include a second cylinder internal to, and concentric with, the first cylinder, where the annular space between the pair of concentric cylinders forms the fluid path. The reactor chamber is oscillated through an arc of between approximately 50 and 90 degrees along an axis perpendicular to the axis of the flow of fluid through the reactor. The oscillatory motion in combination with the flow through the reactor maintains the particles in a fluidized state, preventing packing and maximizi The United States has rights in this invention pursuant to National Institutes of Health Grant No. 5-RO1-GM25810-08.

Inventors

  • 👤 Lisa E. Freed
  • 👤 Jill R. C. Kadam
  • 👤 Philip A. Drinker
  • 👤 J. Richard Thebeau
  • 👤 Robert S. Langer

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-03 00:29
CPC Classifications
A; A61; A61M; A61M1/00; A61M1/36; A61M1/3687; Y; Y10; Y10S; Y10S604/00; Y10S604/903

Claims Analysis

Total Claims: 21
Claim 1
Independent Claim 65 words
An apparatus for the selective treatment of a biological fluid comprising: a reactor chamber; inlet means to the reactor chamber; outlet means from the reactor chamber; particulate material reacting with specific chemical species in the fluid, said material being contained within said chamber by retaining means; and oscillating means for moving said chamber circumferentially about the axis along which the fluid to be treated flows.
Claim 2
Independent Claim 65 words
An apparatus for the selective treatment of a biological fluid comprising: a reactor chamber; inlet means to the reactor chamber; outlet means from the reactor chamber; particulate material reacting with specific chemical species in the fluid, said material being contained within said chamber by retaining means; and oscillating means for moving said chamber circumferentially about the axis along which the fluid to be treated flows.
Claim 3
Dependent Claim 13 words
The apparatus of claim 1 wherein said reactor chamber is a hollow cylinder.
Claim 4
Dependent Claim 31 words
The apparatus of claim 1 wherein said reactor chamber is formed by the annular space between a first cylinder and a second cylinder, said first cylinder located within said second cylinder.
Claim 5
Dependent Claim 44 words
The apparatus of claim 1 wherein said oscillating means torsionally oscillates said reactor chamber at a rate proportional to the fluid flow rate through said chamber to produce counter-rotating secondary flow cells in said fluid, said flow cells maintaining said particulate material in suspension.
Claim 6
Dependent Claim 21 words
The apparatus of claim 1 wherein said particulate material comprises porous particles with diameters of between approximately 10 and 400 micrometers.
Claim 7
Dependent Claim 23 words
The apparatus of claim 1 wherein said material is selected from the group consisting of cellulose, agarose, polymethacrylate, polyurethane, polystyrene, and combinations thereof.
Claim 8
Dependent Claim 22 words
The apparatus of claim 5 wherein said retaining means is a restraining mesh having a pore size less than the particle diameters.
Claim 9
Dependent Claim 29 words
The apparatus of claim 1 wherein said particulate material includes a compound selected from the group consisting of enzymes, antibodies, receptors, anti-toxins, cofactors, drugs, dyes, carbohydrates and combinations thereof.
Claim 10
Dependent Claim 18 words
The apparatus of claim 8 wherein said compound is heparinase and said particulate material is crosslinked agarose beads.
Claim 11
Independent Claim 134 words
A method for the selective treatment of a biological fluid, said method comprising: (a) providing fluid treatment apparatus which comprises: (i) a reactor chamber; (ii) means for forming an inlet to the reactor chamber; (iii) means for forming an outlet to the reactor chamber; (iv) particulate material for reacting with specific chemical species in the fluid, said material being contained within said chamber by retaining means; and (v) means for oscillating said chamber circumferentially about the axis along which the fluid to be treated flows; and (b) flowing said fluid to be treated through the fluid treatment apparatus while simultaneously oscillating the reaction chamber circumferentially about the axis along which the fluid to be treated flows, said oscillation producing counter-rotating secondary flow cells in said fluid to thereby maintain said particulate material in suspension.
Claim 12
Independent Claim 134 words
A method for the selective treatment of a biological fluid, said method comprising: (a) providing fluid treatment apparatus which comprises: (i) a reactor chamber; (ii) means for forming an inlet to the reactor chamber; (iii) means for forming an outlet to the reactor chamber; (iv) particulate material for reacting with specific chemical species in the fluid, said material being contained within said chamber by retaining means; and (v) means for oscillating said chamber circumferentially about the axis along which the fluid to be treated flows; and (b) flowing said fluid to be treated through the fluid treatment apparatus while simultaneously oscillating the reaction chamber circumferentially about the axis along which the fluid to be treated flows, said oscillation producing counter-rotating secondary flow cells in said fluid to thereby maintain said particulate material in suspension.
Claim 13
Dependent Claim 13 words
The method of claim 10 wherein said reaction chamber comprises a hollow cylinder.
Claim 14
Dependent Claim 32 words
The method of claim 10 wherein said reaction chamber comprises an annular space between a first cylinder and a second cylinder, said first cylinder located within and concentric to said second cylinder.
Claim 15
Dependent Claim 33 words
The method of claim 10 wherein said particulate material comprises porous particles having diameters of between about 10 microns and about 400 microns, said particulate material having a biologically active material contained thereon.
Claim 16
Dependent Claim 24 words
The method of claim 13 wherein said particulate material is selected from the group consisting of cellulose, agarose, polymethacrylate, polyurethane, polystyrene and combinations thereof.
Claim 17
Dependent Claim 30 words
The method of claim 13 wherein said biologically active material comprises a compound selected from the group consisting of enzymes, antibodies, receptors, anti-toxins, cofactors, drugs, carbohydrates, dyes and combinations thereof.
Claim 18
Dependent Claim 12 words
The method of claim 15 wherein said biologically active material comprises heparinase.
Claim 19
Dependent Claim 14 words
The method of claim 16 wherein said fluid to be treated comprises heparinized blood.
Claim 20
Dependent Claim 21 words
The method of claim 17 wherein said fluid treatment apparatus is employed in an extracorporeal circuit for treatment of heparinized blood.
Claim 21
Dependent Claim 24 words
The method of claim 10 wherein said reaction chamber further contains material selected from the group consisting of ion exchangers and metal binding compounds.

References Cited (Backward Citations)

US3775309A Cited
US4243532A Cited
US4129131A Cited
DE2734741A1 Cited
US4215688A Cited
US4359389A Cited
US4373023A Cited
US4490290A Cited
US4412923A Cited
US4546552A Cited
DE3406562A1 Cited
US4740313A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1992-07-10 1993-01-09 1993-07-11 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1996-07-10 1997-01-09 1997-07-11 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2000-07-10 2001-01-09 2001-07-11 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag